Interview on aminopeptidase A inhibitors: Fabrice Balavoine, Vice-President research and Development Quantum Genomics, Paris
Webcast: November 12, 2018
The panel discussion who follows the several presentations at the KOL Day organized on June 27th in New York.
Quantum Genomics under the spotlight
Webcast: April 20, 2018
Quantum Genomics strengthens its governance
Salt-related high blood pressure: Inefficient patient care, according to Pr. Keith C. Ferdinand, which penalizes African-Americans and obese people. He expects a lot from the new class of drugs developed by QuantumGenomics to improve their situation
This very interesting focus of Profesor Toshiro Fujita on the salt-related hypertension mechanisms, which particularly affect African-American, Asian and obese persons, is supporting our commitment to develop our drug candidate QGC001
Heartfailure is suffering from a lack of effective treatments. We are encouraged by Profesor Leenen’s interest for our drug candidate QGC101